利索-全球专利检索

  1. Login
  2. Sign Up

Search Results

111 records (took 0.029 seconds)

    CUSTOMIZABLE TITRATION FOR AN IMPLANTABLE NEUROSTIMULATOR
    1.
    发明申请
    CUSTOMIZABLE TITRATION FOR AN IMPLANTABLE NEUROSTIMULATOR 有权

    公开(公告)号：US20240399153A1

    公开(公告)日：2024-12-05

    申请号：US18731997

    申请日：2024-06-03

    Applicant: LivaNova USA, Inc.

    Inventor： Scott Stubbs ,  Imad Libbus ,  Scott Mazar ,  Bruce KenKnight ,  Badri Amurthur

    IPC: A61N1/36 ,  A61N1/365 ,  A61N1/372 ,  G16H20/30 ,  G16H40/63

    Abstract: Systems and methods for customizable titration of an implantable neurostimulator are provided. A method of titrating a neurostimulation signal delivered to a patient from an implantable pulse generator includes delivering a first neurostimulation signal with a first set of parameters, increasing a first value of the first neurostimulation signal at a first rate for a first period of time while delivering the first neurostimulation signal, ceasing delivery of the first neurostimulation signal when the first value reaches a first target value, delivering a second neurostimulation signal with a second set of parameters, and increasing the second neurostimulation signal at a second rate for a second period of time while delivering the second neurostimulation signal.

    SYSTEMS AND METHODS FOR ACCELERATION-BASED SEIZURE DETECTION
    6.
    发明申请
    SYSTEMS AND METHODS FOR ACCELERATION-BASED SEIZURE DETECTION 有权

    公开(公告)号：US20230126576A1

    公开(公告)日：2023-04-27

    申请号：US17508539

    申请日：2021-10-22

    Applicant: LivaNova USA, Inc.

    Inventor： Gerrard Merrill Carlson

    IPC: A61N1/36

    Abstract: A seizure detection system comprises a sensor and a control system. The sensor is configured to detect acceleration data associated with a patient’s movements. The control system is programmed to monitor, via the sensor, the acceleration data to detect a seizure precursor event. The control system is further programmed to, upon detection of the seizure precursor event, perform a frequency analysis of the acceleration data to identify a frequency of the patient’s movements. The control system is further programmed to determine that the patient is experiencing a seizure event based on the frequency of the patient’s movements.

    Titration assist system
    7.
    发明授权
    Titration assist system 有权

    公开(公告)号：US11633600B2

    公开(公告)日：2023-04-25

    申请号：US17136804

    申请日：2020-12-29

    Applicant: LivaNova USA, Inc.

    Inventor： Imad Libbus ,  Bruce KenKnight ,  Scott Stubbs ,  Scott Mazar

    IPC: A61N1/36

    Abstract: A neurostimulation system comprises a sensor and a control system. The sensor is configured to detect a cardiac physiological measure of a patient. The control system is programmed to monitor, via the sensor, the cardiac physiological measure during the treatment. The control system is further programmed to detect a change in the cardiac physiological measure during the treatment. The control system is further programmed to determine, based on the detected change in the cardiac physiological measure, a first transition time in a duty cycle of a neurostimulation signal delivered to the patient where the neurostimulation signal transitions between a stimulation OFF period and a stimulation ON period.

    Evaluation of vagus nerve stimulation using heart rate variability analysis
    8.
    发明授权
    Evaluation of vagus nerve stimulation using heart rate variability analysis 有权

    公开(公告)号：US11554263B2

    公开(公告)日：2023-01-17

    申请号：US16422746

    申请日：2019-05-24

    Applicant: LivaNova USA, Inc.

    Inventor： Imad Libbus ,  Bruce D. Nearing ,  Badri Amurthur ,  Bruce H. KenKnight ,  Richard L. Verrier

    IPC: A61N1/36 ,  A61B5/024 ,  A61B5/352 ,  A61B5/366

    Abstract: An implantable vagus nerve stimulation (VNS) system includes a sensor configured to measure ECG data for a patient, a stimulation subsystem configured to deliver VNS to the patient, and a control system configured to perform a heart rate variability analysis with the ECG data. In some aspects, performing the heart rate variability analysis includes measuring R-R intervals between successive R-waves for the ECG data measured during a stimulation period and a baseline period, plotting each R-R interval against an immediately preceding R-R interval for each of the stimulation period and the baseline period, and determining at least one of a standard deviation from an axis of a line perpendicular to an identity line for each of the stimulation period plot and the baseline period plot or a centroid of each of the stimulation period plot and the baseline period plot.

    Neuromodulation therapy for auto-immune and inflammatory disorders
    10.
    发明授权
    Neuromodulation therapy for auto-immune and inflammatory disorders 有权

    公开(公告)号：US11433237B2

    公开(公告)日：2022-09-06

    申请号：US16711309

    申请日：2019-12-11

    Applicant: LivaNova USA, Inc.

    Inventor： Eric Lovett

    IPC: A61N1/36

    Abstract: The present disclosure relates to a method for modulating the nervous system in order to reduce inflammation. The method includes delivering a vagus nerve stimulation (VNS) therapy to a vagus nerve of a patient for the treatment of inflammation according to a first set of parameters. The method further includes delivering a secondary nerve stimulation (SNS) therapy to a secondary nerve of the patient for the treatment of a sleep disorder according to a second set of parameters different from the first set of parameters.

Patent Agency Ranking